Story

Scotts Miracle-Gro Stock Climbs on Q3 Earnings Beat, Reaffirmed Outlook

ENTHMSVIIDZHZH-TWJAKOHI
Jul 29, 20262 min read
Scotts Miracle-Gro Stock Climbs on Q3 Earnings Beat, Reaffirmed Outlook
Text size
Background

Scotts Miracle-Gro (NYSE: SMG) shares rose in pre-market trading after the company posted stronger-than-expected fiscal third-quarter profits and provided an updated full-year outlook, signaling stability in its first report under a new chief executive.

Key Financial Results

The company reported fiscal third-quarter earnings per share (EPS) of $2.82, significantly exceeding the Wall Street consensus estimate of $2.48. Revenue for the quarter came in at $1.17 billion, which was in line with analyst expectations, according to its earnings release on July 29, 2026.

This performance marks the first quarterly report under the leadership of CEO Nate Baxter, who assumed the role in late June 2026 following the departure of Jim Hagedorn. The positive results suggest a steady operational footing during the leadership transition.

Outlook and Shareholder Returns

Looking ahead, Scotts Miracle-Gro issued updated guidance for the full fiscal year 2026, projecting EPS in the range of $4.30 to $4.45. This forecast straddles the prior analyst consensus of $4.35, indicating management's confidence in maintaining profitability for the remainder of the year.

Sample IUX Markets – In-articleAd

Reinforcing its commitment to shareholder returns, the company's board also approved a quarterly cash dividend of $0.66 per share. The dividend is payable on September 4, 2026, to shareholders of record as of August 21, 2026.

Market Reaction and Context

In response to the news, shares of Scotts Miracle-Gro climbed 1.4% in pre-open trading, pushing the stock toward the upper end of its 52-week range of $52.00 to $75.34. The combination of an earnings beat, stable revenue, and confident guidance appeared to boost investor sentiment.

Prior to the report, analysts held a mean price target of $74.17 on the stock. Analysts at UBS, who maintain a Neutral rating and a $70 price target, had previously noted potential commodity inflation in inputs like urea as a factor to monitor for fiscal 2027.

Read next

More on Stocks
Back to latest news

LATEST